8.19
Palatin Technologies Inc stock is traded at $8.19, with a volume of 14,212.
It is down -4.21% in the last 24 hours and down -30.59% over the past month.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
See More
Previous Close:
$8.55
Open:
$8.93
24h Volume:
14,212
Relative Volume:
0.74
Market Cap:
$14.59M
Revenue:
$12.88M
Net Income/Loss:
$-6.25M
P/E Ratio:
-5.9921
EPS:
-1.3668
Net Cash Flow:
$-14.98M
1W Performance:
-12.96%
1M Performance:
-30.59%
6M Performance:
-55.75%
1Y Performance:
+0.00%
Palatin Technologies Inc Stock (PTN) Company Profile
Name
Palatin Technologies Inc
Sector
Industry
Phone
609-495-2200
Address
4B CEDAR BROOK DRIVE, CRANBURY
Compare PTN vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PTN
Palatin Technologies Inc
|
8.19 | 14.59M | 12.88M | -6.25M | -14.98M | -1.3668 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.22 | 122.98B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
216.25 | 86.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.12 | 77.54B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
802.64 | 50.47B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
188.44 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Palatin Technologies Inc Stock (PTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Laidlaw | Buy |
| Dec-03-25 | Initiated | Alliance Global Partners | Buy |
| Jun-05-15 | Reiterated | Canaccord Genuity | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| May-23-12 | Initiated | Noble Financial | Buy |
| Jan-23-07 | Initiated | Next Generation | Buy |
View All
Palatin Technologies Inc Stock (PTN) Latest News
Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update - Lelezard
Palatin Technologies Earnings Call: Science vs. Cash - TipRanks
Palatin (PTN) Q4 2026 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Palatin Technologies posts progress in Q4 2026, shares volatile - Investing.com
Earnings call transcript: Palatin Technologies posts progress in Q4 2026, shares volatile - Investing.com Canada
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - PR Newswire
A $7.5 million cash balance is not expected to cover a year of operations, Palatin says - stocktitan.net
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - TradingView
Palatin Technologies (PTN) Slips 5.89% to $10.22 as Shares Approach Key SupportSector Neutral Pair - dars.gov.et
Palatin Technologies, Inc. Common Stock (NYSE: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - Kalkine
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction & Forecast 20262030 - BeInCrypto
PTN to SGD: Palatin Technologies, Inc. Common Stock (Backpack Securities) Price in Singapore Dollar - CoinGecko
Palatin Technologies, Inc. Common Stock (Backpack Securities) Price History: Download PTN Historical Data - CoinGecko
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction for 2026 to 2031 - Bybit
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction for 2026 to 2031 - Bybit
Palatin Technologies, Inc. Common Stock (NYSE: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.ca
Palatin Technologies, Inc. Common Stock (Backpack Securities) Price - Bybit
Palatin Technologies Stock Price Forecast. Should You Buy PTN? - StockInvest.us
Palatin Technologies Inc. (PTN) Peer Comparison – Compare with Others - valueresearchonline.com
Debt to equity ratio of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Palatin Technologies Inc. (PTN) Key Financial Ratios – Valuation, Profitability & More - Value Research
Palatin (PTN): Ends Down by 7.23% at $9.69 at the Close; Next Session: Price Remains Between $9.21 Support and $10.17 Resistance under the Current SnapshotSchiff Line - vinanet.vn
Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.ca
Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - Kalkine
Palatin Technologies (PTN) gains 4.7% stake holder AuGC BioFund in 13G/A - Stock Titan
PTN Q2 2026 Earnings: Loss of -$0.37 per Share Beats Estimates by 70.54%; Shares Jump 27.46%Analyst Consensus Shift - vinanet.vn
Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Palatin Technologies Inc (PTN) Stock News Today - TradingKey
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Nasdaq
Q3 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Barchart.com
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Yahoo Finance
Palatin Technologies (PTN) director granted new 2,900-share stock option - stocktitan.net
Palatin Technologies (PTN) director receives 2,400 new stock options - stocktitan.net
Palatin Technologies (PTN) director receives 2,200 options at $7.70 - stocktitan.net
Palatin Technologies Shareholders Back Governance and Incentive Plan - The Globe and Mail
Palatin Technologies Shareholders Back Governance and Incentive Plan - TipRanks
PTN Q2 2026 Earnings: Significant EPS Beat Amid Pipeline Progress and Cost DisciplineEarnings Recovery Stocks - dars.gov.et
Palatin Technologies (PTN) Slides 3.3% as Biotech Sector Faces HeadwindsRisk Reversal - vinanet.vn
Palatin Technologies Surges 10.7%: Key Levels to Watch for PTNBearish Sentiment - siam.in
Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Palatin Technologies Inc (PTN) Balance Sheet - TradingKey
Palatin Technologies Inc (PTN) Income Statement - TradingKey
Palatin Technologies Inc (PTN) Institutional Confidence - TradingKey
TradingKey - TradingKey
Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PTN|Palatin Technologies Inc|Price:7.800|Chg%:+0.095 - TradingKey
PTN|Palatin Technologies Inc|Price:7.705|Chg%:-0.490 - TradingKey
Palatin Technologies Inc (PTN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Palatin Technologies Inc Stock (PTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palatin Technologies Inc Stock (PTN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WILLS STEPHEN T | Director |
Dec 24 '25 |
Proposed Sale |
16.74 |
565 |
9,461 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):